Copeland Capital Management LLC lifted its stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 22.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,049,214 shares of the company’s stock after purchasing an additional 368,984 shares during the quarter. Copeland Capital Management LLC owned 1.51% of Perrigo worth $69,571,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of PRGO. CWM LLC grew its holdings in Perrigo by 73.0% during the 1st quarter. CWM LLC now owns 699 shares of the company’s stock worth $25,000 after acquiring an additional 295 shares during the last quarter. Stone House Investment Management LLC bought a new position in Perrigo in the first quarter worth approximately $27,000. Dark Forest Capital Management LP acquired a new stake in Perrigo in the 1st quarter valued at $31,000. Parallel Advisors LLC increased its position in shares of Perrigo by 434.8% during the first quarter. Parallel Advisors LLC now owns 1,214 shares of the company’s stock worth $44,000 after acquiring an additional 987 shares in the last quarter. Finally, NewEdge Advisors LLC increased its holdings in Perrigo by 345.5% during the 1st quarter. NewEdge Advisors LLC now owns 1,430 shares of the company’s stock worth $51,000 after purchasing an additional 1,109 shares in the last quarter. 95.74% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
PRGO has been the topic of a number of recent analyst reports. StockNews.com upgraded Perrigo from a “hold” rating to a “buy” rating in a report on Wednesday, August 16th. JPMorgan Chase & Co. lifted their price objective on shares of Perrigo from $45.00 to $48.00 and gave the company an “overweight” rating in a research note on Wednesday, August 9th.
Get Our Latest Report on PRGO
Perrigo Stock Performance
Shares of Perrigo stock opened at $32.68 on Friday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.52 and a current ratio of 2.62. Perrigo Company plc has a 52-week low of $30.78 and a 52-week high of $41.44. The company’s 50 day moving average price is $35.96 and its 200-day moving average price is $35.14.
Perrigo (NYSE:PRGO – Get Free Report) last issued its quarterly earnings results on Tuesday, August 8th. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.09. Perrigo had a positive return on equity of 6.79% and a negative net margin of 1.22%. The company had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.18 billion. During the same period in the prior year, the firm earned $0.43 earnings per share. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. On average, sell-side analysts forecast that Perrigo Company plc will post 2.6 EPS for the current year.
Perrigo Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 1st were paid a $0.273 dividend. The ex-dividend date of this dividend was Thursday, August 31st. This represents a $1.09 dividend on an annualized basis and a dividend yield of 3.34%. Perrigo’s dividend payout ratio (DPR) is currently -259.52%.
Perrigo Profile
(Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
Featured Articles
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Perrigo, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Perrigo wasn’t on the list.
While Perrigo currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today’s market? Click the link below and we’ll send you MarketBeat’s list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Source link
credite